Luckily, there are a number of ways to help cut the costs of this treatment, allowing you to pamper yourself for a better ...

NEXGEL (NXGL) issued a letter to its shareholders from Chief Executive Officer, Adam Levy, and is providing guidance for 2024 and 2025. “2024 ...

Shine bright like a diamond, literally.

It's back in stock for a limited time.

Management expects 2024 fourth quarter revenue of approximately $3.0 million and full year 2024 of approximately $8.6 million, representing growth year-over-year of over 100% for the third consecutive ...

Medically reviewed by Laura Young, MD Polycystic ovary syndrome (PCOS) is one of the most common hormonal and metabolic ...

Management expects 2024 fourth quarter revenue of approximately $3.0 million and full year 2024 of approximately $8.6 million, representing growth year-over-year of over 100% for the third consecutive ...